Jeito Capital expands investment team with two senior London hires

Jeito Capital, a biopharma-focused private equity firm, has beefed up its investment team by bringing in seasoned professionals Magdalena Jonikas and Anastasiya Sybirna from London. Jonikas and Sybirna bring extensive experience that will likely enhance Jeito Capital's ability to make strategic investments in the biopharma sector. This expansion into the UK market signals the firm's commitment to growing its influence in the European biotech landscape, which could lead to more significant deals and innovations in the life sciences industry.